<DOC>
	<DOC>NCT00519623</DOC>
	<brief_summary>This study is designed to evaluate the pharmacokinetics/pharmacodynamics of an investigational basal insulin patch in type 1 diabetes patients.</brief_summary>
	<brief_title>Transdermal Basal Insulin Patch Study in Type 1 Diabetes</brief_title>
	<detailed_description>The study is looking for patients that meet the following criteria: - Duration of type diabetes greater than or equal to 10 years - HbA1C less than or equal to 9.0% - C-peptide negative - Ages 18 - 65, male or female - Body Mass Index (BMI) 18.5 - 32 - Non-smoker - No advanced diabetes complications - Not pregnant or breast feeding</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Duration of type 1 diabetes greater than or equal to 10 years HbA1c less than or equal to 9.0% Cpeptide negative Ages 18 65, male or female BMI 18.5 32 Non smoker No advance diabetes complications Not pregnant or breast feeding Arm or leg rashes, open wounds, or skin conditions Psychiatric disorders Participation in a clinical research trial in last 3 months Clinically significant acute illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>diabetes</keyword>
	<keyword>insulin</keyword>
	<keyword>blood sugar</keyword>
	<keyword>type 1 diabetes</keyword>
	<keyword>insulin dependent diabetes</keyword>
	<keyword>transdermal</keyword>
</DOC>